| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aligos Therapeutics, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 75,000 | 08 Oct 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ALGS | Aligos Therapeutics, Inc. | 08 Oct 2024 | 1 | $0 | 4 | Chief Medical Officer | 10 Oct 2024, 16:16 |
| ALGS | Aligos Therapeutics, Inc. | 23 Sep 2024 | 0 | $0 | 3 | Chief Medical Officer | 26 Sep 2024, 16:15 |